Enteric lactoferrin attenuates the development of high-fat and high-cholesterol diet-induced hypercholesterolemia and atherosclerosis in Microminipigs
Open Access
- 1 February 2016
- journal article
- research article
- Published by Taylor & Francis in Bioscience, Biotechnology, and Biochemistry
- Vol. 80 (2) , 295-303
Abstract
Previously, we found that enteric lactoferrin (eLF) could reduce the visceral fat accumulation known to associate strongly with metabolic syndrome symptoms and consequently with an increased risk of atherosclerosis. In this study, the atherosclerosis-preventive potential of LF was assessed in a high-fat and high-cholesterol diet (HFCD)-induced hypercholesterolemia and atherosclerosis model using Microminipig™. Eight-week orally administered eLF remarkably reduced the HFCD-induced serum total and low-density lipoprotein cholesterol levels but not high-density lipoprotein cholesterol levels. A histological analysis of 15 arteries revealed that eLF systemically inhibited the development of atherosclerotic lesions. Pathway analysis using identified genes that characterized eLF administration in liver revealed significant changes in the steroid biosynthesis pathway (ssc00100) and all affected genes in this pathway were upregulated, suggesting that cholesterol synthesis inhibited by HFCD was recovered by eLF. In summary, eLF could potentially prevent the hypercholesterolemia and atherosclerosis through protecting homeostasis from HFCD-induced dysfunction of cholesterol metabolism.Keywords
This publication has 39 references indexed in Scilit:
- Dietary Lactoferrin Alleviates Age-Related Lacrimal Gland Dysfunction in MicePLOS ONE, 2012
- Metabolic effects of lactoferrin during energy restriction and weight regain in diet-induced obese miceJournal of Functional Foods, 2012
- Effect of mild restriction of food intake on gene expression profile in the liver of young rats: reference data for in vivo nutrigenomics studyBritish Journal of Nutrition, 2010
- Effect of Orally Administered Bovine Lactoferrin on the Growth of Adenomatous Colorectal Polyps in a Randomized, Placebo-Controlled Clinical TrialCancer Prevention Research, 2009
- Lactoferrin increases 172ThrAMPK phosphorylation and insulin-induced p473SerAKT while impairing adipocyte differentiationInternational Journal of Obesity, 2009
- Ranking differentially expressed genes from Affymetrix gene expression data: methods with reproducibility, sensitivity, and specificityAlgorithms for Molecular Biology, 2009
- Systematic and integrative analysis of large gene lists using DAVID bioinformatics resourcesNature Protocols, 2008
- A distribution free summarization method for Affymetrix GeneChip® arraysBioinformatics, 2006
- Lactoferrin inhibits cholesterol accumulation in macrophages mediated by acetylated or oxidized low-density lipoproteinsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1994
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993